Benedict Seddon

Benedict Seddon

Auto-generated profile, based on publicly available information

Benedict Seddon

Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2009 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DGDuncan M Gascoyne
Duncan M Gascoyne
ELElaine Long
Elaine Long
HVHenrique Veiga-Fernandes
Henrique Veiga-Fernandes
Jasper de BoerJasper de Boer
Jasper de Boer
OWOwen Williams
Owen Williams
HBHugh J M Brady
Hugh J M Brady

15 June 2003 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
BSBenedict Seddon
Benedict Seddon
PTPeter Tomlinson
Peter Tomlinson
RZRose Zamoyska
Rose Zamoyska

19 November 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
João T BarataJoão T Barata
João T Barata
SDScott K. Durum
Scott K. Durum
BSBenedict Seddon
Benedict Seddon

1 March 1999 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
BSBenedict Seddon
Benedict Seddon
DMDon Mason
Don Mason
Previous studies have shown that autoimmune thyroiditis can be induced in normal laboratory rats after thymectomy and split dose γ-irradiation. Development of disease can be prevented by reconstitution of PVG rats shortly after their final irradiation with either peripheral CD4+CD45RC− T cells or CD4+CD8− thymocytes from syngeneic donors. Although the activity of both populations is known to depend on the activities of endogenously produced interleukin 4 and transforming growth factor β, implying a common mechanism, the issue of antigen specificity of the cells involved has not yet been addressed. In this study, we show that the regulatory T cells that prevent autoimmune thyroiditis are generated in vivo only when the relevant autoantigen is also present. Peripheral CD4+ T cells, from rats whose thyroids were ablated in utero by treatment with 131I, were unable to prevent disease development upon adoptive transfer into thymectomized and irradiated recipients. This regulatory deficit is specific for thyroid autoimmunity, since CD4+ T cells from 131I-treated PVG.RT1u rats were as effective as those from normal donors at preventing diabetes in thymectomized and irradiated PVG.RT1u rats. Significantly, in contrast to the peripheral CD4+ T cells, CD4+CD8− thymocytes from 131I-treated PVG donors were still able to prevent thyroiditis upon adoptive transfer. Taken together, these data indicate that it is the peripheral autoantigen itself that stimulates the generation of the appropriate regulatory cells from thymic emigrant precursors.

18 January 1999 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
BSBenedict Seddon
Benedict Seddon
DMDon Mason
Don Mason
Previous studies have shown that induction of autoimmune diabetes by adult thymectomy and split dose irradiation of PVG.RT1u rats can be prevented by their reconstitution with peripheral CD4+CD45RC−TCR-α/β+RT6+ cells and CD4+CD8− thymocytes from normal syngeneic donors. These data provide evidence for the role of regulatory T cells in the prevention of a tissue-specific autoimmune disease but the mode of action of these cells has not been reported previously. In this study, autoimmune thyroiditis was induced in PVG.RT1c rats using a similar protocol of thymectomy and irradiation. Although a cell-mediated mechanism has been implicated in the pathogenesis of diabetes in PVG.RT1u rats, development of thyroiditis is independent of CD8+ T cells and is characterized by high titers of immunoglobulin (Ig)G1 antithyroglobulin antibodies, indicating a major humoral component in the pathogenesis of disease. As with autoimmune diabetes in PVG.RT1u rats, development of thyroiditis was prevented by the transfer of CD4+CD45RC− and CD4+CD8− thymocytes from normal donors but not by CD4+CD45RC+ peripheral T cells. We now show that transforming growth factor (TGF)-β and interleukin (IL)-4 both play essential roles in the mechanism of this protection since administration of monoclonal antibodies that block the biological activity of either of these cytokines abrogates the protective effect of the donor cells in the recipient rats. The prevention of both diabetes and thyroiditis by CD4+CD45RC− peripheral cells and CD4+CD8− thymocytes therefore does not support the view that the mechanism of regulation involves a switch from a T helper cell type 1 (Th1) to a Th2-like response, but rather relies upon a specific suppression of the autoimmune responses involving TGF-β and IL-4. The observation that the same two cytokines were implicated in the protective mechanism, whether thymocytes or peripheral cells were used to prevent autoimmunity, strongly suggests that the regulatory cells from both sources act in the same way and that the thymocytes are programmed in the periphery for their protective role. The implications of this result with respect to immunological homeostasis are discussed.

29 October 2001 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KSKaty Smith
Katy Smith
BSBenedict Seddon
Benedict Seddon
MPMarco A. Purbhoo
Marco A. Purbhoo
RZRose Zamoyska
Rose Zamoyska
AFAmanda G. Fisher
Amanda G. Fisher
MMMatthias Merkenschlager
Matthias Merkenschlager
T cell receptor interactions with peptide/major histocompatibility complex (pMHC) ligands control the selection of T cells in the thymus as well as their homeostasis in peripheral lymphoid organs. Here we show that pMHC contact modulates the expression of CD5 by naive CD4 T cells in a process that requires the continued expression of p56lck. Reduced CD5 levels in T cells deprived of pMHC contact are predictive of elevated Ca2+ responses to subsequent TCR engagement by anti-CD3 or nominal antigen. Adaptation to peripheral pMHC contact may be important for regulating naive CD4 T cell responsiveness.